These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37113740)

  • 21. Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy.
    Della Polla G; Miraglia Del Giudice G; Folcarelli L; Napoli A; Angelillo IF;
    Front Public Health; 2022; 10():1051035. PubMed ID: 36568799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
    Bor J; Assoumou SA; Lane K; Diaz Y; Ojikutu BO; Raifman J; Levy JI
    PLoS Med; 2023 Jan; 20(1):e1004167. PubMed ID: 36719864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The way forward to achieve high COVID-19 vaccination and revaccination coverage in a city amid a period of tranquility.
    Kwok KO; Li KK; Leung CLK; Tang A; Chan EYY; Tsoi MTF; Wei WI; McNeil EB; Wong SYS
    Front Public Health; 2022; 10():935243. PubMed ID: 36187671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination Intention Following Receipt of Vaccine Information Through Interactive Simulation vs Text Among COVID-19 Vaccine-Hesitant Adults During the Omicron Wave in Germany.
    Wegwarth O; Mansmann U; Zepp F; Lühmann D; Hertwig R; Scherer M
    JAMA Netw Open; 2023 Feb; 6(2):e2256208. PubMed ID: 36795411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China.
    Qin W; Zhang X; Wang Y; Pan F; Cheng K; Huang F; Song J; Su H
    Front Public Health; 2022; 10():943876. PubMed ID: 35979461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining the Prevalence and Correlates of COVID-19 Booster Vaccine Hesitancy in the Singapore Population Following the Completion of the Primary Vaccination Series.
    Tan KYK; Soh ASE; Ong BWL; Chen MI; Griva K
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study.
    Allen K; Lambert SB; Yuen A; Pourmarzi D
    BMC Public Health; 2022 Nov; 22(1):2205. PubMed ID: 36443806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort.
    Smoot K; Yang J; Tacker DH; Welch S; Khodaverdi M; Kimble W; Wen S; Amjad A; Marsh C; Perrotta PL; Hodder S
    JAMA Netw Open; 2022 Sep; 5(9):e2231334. PubMed ID: 36098966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "I don't see an added value for myself": a qualitative study exploring the social cognitive variables associated with influenza vaccination of Belgian, Dutch and German healthcare personnel.
    Lehmann BA; Ruiter RA; Wicker S; van Dam D; Kok G
    BMC Public Health; 2014 Apr; 14():407. PubMed ID: 24775096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.
    Schiavoni I; Palmieri A; Olivetta E; Leone P; Di Lonardo A; Mazzoli A; Cafariello C; Malara A; Palamara AT; Incalzi RA; Onder G; Stefanelli P; Fedele G;
    J Am Med Dir Assoc; 2023 Feb; 24(2):140-147.e2. PubMed ID: 36587928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19-Related Burnout and Intention of Fully Vaccinated Individuals to Get a Booster Dose: The Mediating Role of Resilience.
    Galanis P; Katsiroumpa A; Sourtzi P; Siskou O; Konstantakopoulou O; Katsoulas T; Kaitelidou D
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 booster vaccine willingness.
    Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Dec; 69(1):. PubMed ID: 34913428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022.
    Natarajan K; Prasad N; Dascomb K; Irving SA; Yang DH; Gaglani M; Klein NP; DeSilva MB; Ong TC; Grannis SJ; Stenehjem E; Link-Gelles R; Rowley EA; Naleway AL; Han J; Raiyani C; Benitez GV; Rao S; Lewis N; Fadel WF; Grisel N; Griggs EP; Dunne MM; Stockwell MS; Mamawala M; McEvoy C; Barron MA; Goddard K; Valvi NR; Arndorfer J; Patel P; Mitchell PK; Smith M; Kharbanda AB; Fireman B; Embi PJ; Dickerson M; Davis JM; Zerbo O; Dalton AF; Wondimu MH; Azziz-Baumgartner E; Bozio CH; Reynolds S; Ferdinands J; Williams J; Schrag SJ; Verani JR; Ball S; Thompson MG; Dixon BE
    MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(13):495-502. PubMed ID: 35358170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 vaccination attitudes and intention among Quebecers during the first and second waves of the pandemic: findings from repeated cross-sectional surveys.
    Dubé È; Dionne M; Pelletier C; Hamel D; Gadio S
    Hum Vaccin Immunother; 2021 Nov; 17(11):3922-3932. PubMed ID: 34236949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parents' intention to get vaccinated and to have their child vaccinated against COVID-19: cross-sectional analyses using data from the KUNO-Kids health study.
    Brandstetter S; Böhmer MM; Pawellek M; Seelbach-Göbel B; Melter M; Kabesch M; Apfelbacher C;
    Eur J Pediatr; 2021 Nov; 180(11):3405-3410. PubMed ID: 33999257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitudes towards vaccines and intention to vaccinate against COVID-19: a cross-sectional analysis-implications for public health communications in Australia.
    Enticott J; Gill JS; Bacon SL; Lavoie KL; Epstein DS; Dawadi S; Teede HJ; Boyle J;
    BMJ Open; 2022 Jan; 12(1):e057127. PubMed ID: 34980631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attitudes toward Receiving COVID-19 Booster Dose in the Middle East and North Africa (MENA) Region: A Cross-Sectional Study of 3041 Fully Vaccinated Participants.
    Abouzid M; Ahmed AA; El-Sherif DM; Alonazi WB; Eatmann AI; Alshehri MM; Saleh RN; Ahmed MH; Aziz IA; Abdelslam AE; Omran AA; Omar AA; Ghorab MA; Islam SMS
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A positive update on COVID-19 booster vaccine willingness among Danes.
    Sønderskov KM; Vistisen HT; Dinesen PT; Østergaard SD
    Dan Med J; 2022 Jan; 69(2):. PubMed ID: 35088699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual-level social capital and COVID-19 vaccine hesitancy in Japan: a cross-sectional study.
    Machida M; Kikuchi H; Kojima T; Nakamura I; Saito R; Nakaya T; Hanibuchi T; Takamiya T; Odagiri Y; Fukushima N; Amagasa S; Watanabe H; Inoue S
    Hum Vaccin Immunother; 2022 Nov; 18(5):2086773. PubMed ID: 35708308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.